TEVA icon

Teva Pharmaceuticals

576 hedge funds and large institutions have $14.7B invested in Teva Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 96 funds opening new positions, 192 increasing their positions, 189 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more funds holding in top 10

Funds holding in top 10:

7% more funds holding

Funds holding: 537576 (+39)

2.69% more ownership

Funds ownership: 55.98%58.67% (+2.7%)

2% more repeat investments, than reductions

Existing positions increased: 192 | Existing positions reduced: 189

Holders
576
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
36
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$727M
Puts
$402M
Net Calls
Net Calls Change

Top Buyers

1 +$424M
2 +$167M
3 +$150M
4
CI
Clal Insurance
Israel
+$97.5M
5
PC
PointState Capital
New York
+$83M

Top Sellers

1 -$174M
2 -$116M
3 -$114M
4
Neuberger Berman Group
Neuberger Berman Group
New York
-$85.6M
5
Deutsche Bank
Deutsche Bank
Germany
-$59.7M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$1.81B
2
$1.11B
3
$860M
4
$808M
5
$626M
6
$599M
7
$574M
8
$468M
9
$428M
10
$375M
11
$329M
12
$298M
13
$204M
14
$203M
15
$198M
16
$187M
17
$186M
18
$154M
19
$154M
20
$148M
21
$144M
22
$143M
23
$134M
24
$115M
25
$114M